Skip to main content
Top
Published in: Internal and Emergency Medicine 5/2011

01-10-2011 | IM - CASE RECORD

Terlipressin infusion induces Tako-Tsubo syndrome in a cirrhotic man with hepato-renal syndrome

Authors: Antonio Di Micoli, Daniela Buccione, Daniela Degli Esposti, Valentina Santi, Luciana Bastagli, Claudio Borghi, Mauro Bernardi, Franco Trevisani

Published in: Internal and Emergency Medicine | Issue 5/2011

Login to get access

Excerpt

Dr. Di Micoli, Dr. Buccione, Prof. Trevisani: Tako-Tsubo cardiomyopathy (TTC), also known as transient left ventricular apical ballooning syndrome, is a clinical entity characterized by (1) reversible left ventricular apical wall motion abnormalities, (2) typical electrocardiographic changes and (3) relatively minor elevation of troponine, creatinine-kinase (CK) and CK-MB that mimics an acute myocardial infarction (AMI) without any acute obstructive coronary disease [1]. Typically, the left ventricular imbalance almost always recovers in a period of days to weeks, so that the management and prognosis of this condition are clearly different from those of AMI [2]. TTC is generally observed in post-menopausal women without prior history of heart disease or clear risk factors for coronary artery disease, who have often experienced recent emotional or physical stress, non-cardiac surgery or extracardiac diseases [1]. Recently, TTC has also been described in critically ill patients without prior heart disease admitted to a medical intensive care unit for severe non-cardiac diseases, such as sepsis, acute respiratory failure, systemic inflammatory response syndrome, anaphylaxis and trauma injuries [3, 4]. …
Literature
1.
go back to reference Hansen PR (2007) Takotsubo cardiomyopathy: an under-recognized myocardial syndrome. Eur J Intern Med 18:561–565PubMedCrossRef Hansen PR (2007) Takotsubo cardiomyopathy: an under-recognized myocardial syndrome. Eur J Intern Med 18:561–565PubMedCrossRef
2.
go back to reference Park SM, Prasad A, Rihal C, Bell MR, Oh JK (2009) Left ventricular systolic and diastolic function in patients with apical ballooning syndrome compared with patients with acute anterior ST-segment elevation myocardial infarction: a functional paradox. Mayo Clin Proc 84:514–521PubMedCrossRef Park SM, Prasad A, Rihal C, Bell MR, Oh JK (2009) Left ventricular systolic and diastolic function in patients with apical ballooning syndrome compared with patients with acute anterior ST-segment elevation myocardial infarction: a functional paradox. Mayo Clin Proc 84:514–521PubMedCrossRef
3.
go back to reference Ruiz Bailén M (2002) Reversible myocardial dysfunction in critically ill noncardiac patients: a review. Crit Care Med 30:1280–1290PubMedCrossRef Ruiz Bailén M (2002) Reversible myocardial dysfunction in critically ill noncardiac patients: a review. Crit Care Med 30:1280–1290PubMedCrossRef
4.
go back to reference Zanobetti M, Vicidomini S, Conti A, Innocenti F, Pini R (2010) An atypical case of inverted Tako-Tsubo syndrome: case report and review of the literature. Intern Emerg Med 5:215–219PubMedCrossRef Zanobetti M, Vicidomini S, Conti A, Innocenti F, Pini R (2010) An atypical case of inverted Tako-Tsubo syndrome: case report and review of the literature. Intern Emerg Med 5:215–219PubMedCrossRef
5.
go back to reference Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V (2007) Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56:1310–1318PubMed Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V (2007) Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56:1310–1318PubMed
6.
go back to reference Zambruni A, Di Micoli A, Lubisco A, Domenicali M, Trevisani F, Bernardi M (2007) QT interval correction in patients with cirrhosis. J Cardiovasc Electrophysiol 18:77–82PubMedCrossRef Zambruni A, Di Micoli A, Lubisco A, Domenicali M, Trevisani F, Bernardi M (2007) QT interval correction in patients with cirrhosis. J Cardiovasc Electrophysiol 18:77–82PubMedCrossRef
7.
go back to reference Desmet WJ, Adriaenssens BF, Dens JA (2003) Apical ballooning of the left ventricle: first series in white patients. Heart 89:1027–1031PubMedCrossRef Desmet WJ, Adriaenssens BF, Dens JA (2003) Apical ballooning of the left ventricle: first series in white patients. Heart 89:1027–1031PubMedCrossRef
8.
go back to reference Dote K, Sato H, Tateishi H, Uchida T, Ishihara M (1991) Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases. J Cardiol 21:203–214PubMed Dote K, Sato H, Tateishi H, Uchida T, Ishihara M (1991) Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases. J Cardiol 21:203–214PubMed
9.
go back to reference Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright RS, Rihal CS (2004) Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med 41:858–865 Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright RS, Rihal CS (2004) Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med 41:858–865
10.
go back to reference Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC (2005) Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352:539–548PubMedCrossRef Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC (2005) Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352:539–548PubMedCrossRef
11.
go back to reference Ueyama T (2004) Emotional stress-induced Tako-tsubo cardiomyopathy: animal model and molecular mechanism. Ann N Y Acad Sci 1018:437–444PubMedCrossRef Ueyama T (2004) Emotional stress-induced Tako-tsubo cardiomyopathy: animal model and molecular mechanism. Ann N Y Acad Sci 1018:437–444PubMedCrossRef
12.
go back to reference Kurisu S, Inoue I, Kawagoe T (2003) Myocardial perfusion and fatty acid metabolism in patients with tako-tsubo-like left ventricular dysfunction. J Am Coll Cardiol 41:743–748PubMedCrossRef Kurisu S, Inoue I, Kawagoe T (2003) Myocardial perfusion and fatty acid metabolism in patients with tako-tsubo-like left ventricular dysfunction. J Am Coll Cardiol 41:743–748PubMedCrossRef
13.
go back to reference Berecek KH, Barron KW, Webb RL, Brody MJ (1982) Vasopressin-central nervous system interactions in the development of DOCA hypertension. Hypertension 4:131–137PubMed Berecek KH, Barron KW, Webb RL, Brody MJ (1982) Vasopressin-central nervous system interactions in the development of DOCA hypertension. Hypertension 4:131–137PubMed
14.
go back to reference García-Villalón AL, Garcia JL, Fernández N, Monge L, Gómez B, Diéguez G (1996) Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide. Br J Pharmacol 118:1848–1854PubMed García-Villalón AL, Garcia JL, Fernández N, Monge L, Gómez B, Diéguez G (1996) Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide. Br J Pharmacol 118:1848–1854PubMed
15.
go back to reference Maturi MF, Martin SE, Markle D, Maxwell M, Burruss CR, Speir E, Greene R, Ro YM, Vitale D, Green MV (1991) Coronary vasoconstriction induced by vasopressin. Production of myocardial ischemia in dogs by constriction of non diseased small vessels. Circulation 83:2111–2121PubMed Maturi MF, Martin SE, Markle D, Maxwell M, Burruss CR, Speir E, Greene R, Ro YM, Vitale D, Green MV (1991) Coronary vasoconstriction induced by vasopressin. Production of myocardial ischemia in dogs by constriction of non diseased small vessels. Circulation 83:2111–2121PubMed
16.
go back to reference Walker BR, Childs ME, Adams EM (1988) Direct cardiac effects of vasopressin: role of V1- and V2-vasopressinergic receptors. Am J Physiol 255:261–265 Walker BR, Childs ME, Adams EM (1988) Direct cardiac effects of vasopressin: role of V1- and V2-vasopressinergic receptors. Am J Physiol 255:261–265
17.
go back to reference Ouattara A, Landi M, Le Manach Y, Lecomte P, Leguen M, Boccara G, Coriat P, Riou B (2005) Comparative cardiac effects of terlipressin, vasopressin, and norepinephrine on an isolated perfused rabbit heart. Anesthesiology 102:85–92PubMedCrossRef Ouattara A, Landi M, Le Manach Y, Lecomte P, Leguen M, Boccara G, Coriat P, Riou B (2005) Comparative cardiac effects of terlipressin, vasopressin, and norepinephrine on an isolated perfused rabbit heart. Anesthesiology 102:85–92PubMedCrossRef
18.
go back to reference Medel J, Boccara G, Van de Steen E, Bertrand M, Godet G, Coriat P (2001) Terlipressin for treating intraoperative hypotension: can it unmask myocardial ischemia? Anesth Analg 93:53–55PubMedCrossRef Medel J, Boccara G, Van de Steen E, Bertrand M, Godet G, Coriat P (2001) Terlipressin for treating intraoperative hypotension: can it unmask myocardial ischemia? Anesth Analg 93:53–55PubMedCrossRef
19.
go back to reference Sanyal AJ, Boyer T, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, Blei A, Gülberg V, Sigal S, Teuber P (2008) Terlipressin Study Group. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 134:1360–1368PubMedCrossRef Sanyal AJ, Boyer T, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, Blei A, Gülberg V, Sigal S, Teuber P (2008) Terlipressin Study Group. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 134:1360–1368PubMedCrossRef
20.
go back to reference Krag A, Borup T, Møller S, Bendtsen F (2008) Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome. Adv Ther 25:1105–1140PubMedCrossRef Krag A, Borup T, Møller S, Bendtsen F (2008) Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome. Adv Ther 25:1105–1140PubMedCrossRef
Metadata
Title
Terlipressin infusion induces Tako-Tsubo syndrome in a cirrhotic man with hepato-renal syndrome
Authors
Antonio Di Micoli
Daniela Buccione
Daniela Degli Esposti
Valentina Santi
Luciana Bastagli
Claudio Borghi
Mauro Bernardi
Franco Trevisani
Publication date
01-10-2011
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue 5/2011
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-011-0534-6

Other articles of this Issue 5/2011

Internal and Emergency Medicine 5/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine